Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read Pharma Industry News How the Nautilus Biotechnology and Michael J. Fox Foundation alliance signals a shift in Parkinson’s biomarker strategy (NASDAQ: NAUT) Find out how Nautilus Biotechnology’s Parkinson’s collaboration signals a strategic shift in biomarker platforms and what it means for investors and drug developers. bySoujanya RaviJanuary 31, 2026